Mounjaro 7,5 mg Price France and Belgium – Injectable solution for diabetes and weight control

Introducing Mounjaro 7,5 mg KwikPen

Mounjaro 7,5 mg is a pre-filled pen injectable solution containing tirzepatide, an innovative medication for the treatment of type 2 diabetes and weight management. Each pen delivers four weekly doses of 0,6 ml. Its efficacy is proven in adults with a BMI greater than 27 kg/m², particularly in cases of overweight or obesity with metabolic complications.

Price of Mounjaro 7,5 mg in France and Belgium

The price of Mounjaro 7,5 mg varies depending on the pharmacy:

• France : approximately €395 per pre-filled pen (not reimbursed by Social Security)
• Belgium : between €380 and €400, depending on the pharmacy

Prices may fluctuate depending on dispensing fees and pharmacy availability.

Indications and use

• Used in conjunction with a low-calorie diet and regular physical activity
• Suitable for patients whose type 2 diabetes is inadequately controlled
• Promotes an average weight loss of 15% observed in several clinical studies
• Administered once a week in the abdomen, thigh or arm

Side effects and precautions

The most common side effects are gastrointestinal: nausea, diarrhea, and vomiting. Adequate hydration is essential. Mounjaro should not be used during pregnancy or breastfeeding.

Key benefits

• Sustainable control of type 2 diabetes
• Significant reduction in body weight
• KwikPen is easy to use
• One injection per week

FAQ

Is the Mounjaro refundable?

No, it is not yet reimbursed in France or Belgium.

Can I use it without a prescription?

No, it is only dispensed with a medical prescription.

What is the difference between this and Wegovy or Saxenda?

Mounjaro acts on GIP and GLP-1 receptors, offering a dual action that is often more effective than… wegovy, which acts solely on GLP-1.

Conclusion

Le Mounjaro 7,5 mg It is a comprehensive therapeutic option for people with type 2 diabetes or obesity. Its effectiveness on blood glucose and weight loss, combined with a simple weekly injection, makes it a preferred choice for patients seeking stable metabolic control